European defibrillators market is expected to grow significantly owing to the Sudden Cardiac Death(SCD);and is responsible for about 20% of total mortalities in Europe. Sudden cardiac death claims for more than 350,000 lives per year in Europe. This disease is the predominant risk of death for patients with heart failure. The disease is deadly within minutes if left untreated and its survival rate is just 5%–20%. It is considered as a significant economic burden on a societal basis. Additionally, it is estimated to cost between $860,000 and $1.6 million per case. Moreover, the risk increases for patients suffering from a myocardial infarction. Such high prevalence and mortalities due to cardiac arrest are considered as the most important factors in the defibrillator’s market growth
To Request a Sample of our Report on European Defibrillators Market: https://www.omrglobal.com/request-sample/european-defibrillators-market
European network has been created in the region to find sudden cardiac arrest causes and compare treatments. This network, formerly known as European Sudden Cardiac Arrest network (ESCAPE-NET), is backed by the ERC and European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC). Additionally, it is being funded by a European Union Horizon 2020 grant. 16 scientific teams in ESCAPE-NET across Europe are pooling their expertise and patient populations for creating a database of SCA suffering by the community’s population and it is sufficiently large to study causes, treatments, and prevention strategies. This database includes more than 80,000 SCA patients with around 20,000 DNA samples.
Further, several European policies and regulations are meant to safeguard patients and ensure safety and security of the citizens and keenly observe medical devices and services. Stringent regulations and policies enable to avoid entry of drugs and devices that might be a risk to patients on using medical devices and services, which contributes for significant growth of the defibrillator market.
(Get 15% Discount on Buying this Report)
A full Report of European Defibrillators Market is Available @ https://www.omrglobal.com/industry-reports/european-defibrillators-market
European Defibrillators Market Segmentation
By Type
- Implantable Cardioverter Defibrillators
- External Cardioverter Defibrillators
By End-Users
- Hospitals
- Ambulatory Services and Others
Regional Analysis
- Germany
- UK
- France
- Italy
- Spain
Rest of Europe
Company Profiles
- Abbott Laboratories, Inc.
- Biotronik SE & Co. KG
- Cintas Corp.
- Defibtech, LLC
- General Electric Co.
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic PLC
- Mindray Medical International Co. Ltd.
- Nihon Kohden Corp.
- Stryker Corp.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
